Expression of mutant Sftpc in murine alveolar epithelia drives spontaneous lung fibrosis
Authors:
- Shin-Ichi NurekiSNShin-Ichi Nureki
- Yaniv TomerYTYaniv Tomer
- Alessandro VenosaAVAlessandro Venosa
- Jeremy KatzenJKJeremy Katzen
- Scott J. RussoSRScott J. Russo
- Sarita JamilSJSarita Jamil
- Matthew BarrettMBMatthew Barrett
- Vivian NguyenVNVivian Nguyen
- Meghan KoppMKMeghan Kopp
- Surafel MulugetaSMSurafel Mulugeta
- Michael F. BeersMBMichael F. Beers
Top Cited Papers
Open Access
- 13 August 2018
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 128 (9) , 4008-4024
Abstract
Epithelial cell dysfunction is postulated as an important component in the pathogenesis of idiopathic pulmonary fibrosis (IPF). Mutations in the surfactant protein C (SP-C) gene (SFTPC), an alveolar type II (AT2) cell–restricted protein, have been found in sporadic and familial IPF. To causally link these events, we developed a knockin mouse model capable of regulated expression of an IPF-associated isoleucine-to-threonine substitution at codon 73 (I73T) in Sftpc (SP-CI73T). Tamoxifen-treated SP-CI73T cohorts developed rapid increases in SftpcI73T mRNA and misprocessed proSP-CI73T protein accompanied by increased early mortality (days 7–14). This acute phase was marked by diffuse parenchymal lung injury, tissue infiltration by monocytes, polycellular alveolitis, and elevations in bronchoalveolar lavage and AT2 mRNA content of select inflammatory cytokines. Resolution of alveolitis (2–4 weeks), commensurate with a rise in TGF-β1, was followed by aberrant remodeling marked by collagen deposition, AT2 cell hyperplasia, α–smooth muscle actin–positive (α-SMA–positive) cells, and restrictive lung physiology. The translational relevance of the model was supported by detection of multiple IPF biomarkers previously reported in human cohorts. These data provide proof of principle that mutant SP-C expression in vivo causes spontaneous lung fibrosis, strengthening the role of AT2 cell dysfunction as a key upstream driver of IPF pathogenesis.Keywords
Funding Information
- National Institutes of Health (HL119436)
- National Institutes of Health (HL129150)
- National Institutes of Health (HL007586-31)
- U.S. Department of Veterans Affairs (VA Merit 1l01BX001176)
- NIH (P30 ES13508)
This publication has 74 references indexed in Scilit:
- 4-Phenylbutyric Acid Treatment Rescues Trafficking and Processing of a Mutant Surfactant Protein–CAmerican Journal of Respiratory Cell and Molecular Biology, 2012
- Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary FibrosisNew England Journal of Medicine, 2012
- Multiple ways to die: Delineation of the unfolded protein response and apoptosis induced by Surfactant Protein C BRICHOS mutantsThe International Journal of Biochemistry & Cell Biology, 2012
- Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fibrosisAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- Early Alveolar Epithelial Dysfunction Promotes Lung Inflammation in a Mouse Model of Hermansky-Pudlak SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2011
- A Nonaggregating Surfactant Protein C Mutant Is Misdirected to Early Endosomes and Disrupts Phospholipid RecyclingTraffic, 2011
- Endoplasmic reticulum stress enhances fibrotic remodeling in the lungsProceedings of the National Academy of Sciences, 2011
- Endoplasmic Reticulum Stress Induced by Surfactant Protein C BRICHOS Mutants Promotes Proinflammatory Signaling by Epithelial CellsAmerican Journal of Respiratory Cell and Molecular Biology, 2011
- Targeted Injury of Type II Alveolar Epithelial Cells Induces Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Epithelial Endoplasmic Reticulum Stress and Apoptosis in Sporadic Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2008